These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34391184)

  • 1. The role of anti-inflammatory drugs and nanoparticle-based drug delivery models in the management of ischemia-induced heart failure.
    Haley KE; Almas T; Shoar S; Shaikh S; Azhar M; Cheema FH; Hameed A
    Biomed Pharmacother; 2021 Oct; 142():112014. PubMed ID: 34391184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
    Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
    Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.
    Ong SB; Hernández-Reséndiz S; Crespo-Avilan GE; Mukhametshina RT; Kwek XY; Cabrera-Fuentes HA; Hausenloy DJ
    Pharmacol Ther; 2018 Jun; 186():73-87. PubMed ID: 29330085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented cardiac formation of oxidatively-induced carbonylated proteins accompanies the increased functional severity of post-myocardial infarction heart failure in the setting of type 1 diabetes mellitus.
    Dennis KE; Hill S; Rose KL; Sampson UK; Hill MF
    Cardiovasc Pathol; 2013; 22(6):473-80. PubMed ID: 23566587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction.
    Gullestad L; Orn S; Dickstein K; Eek C; Edvardsen T; Aakhus S; Askevold ET; Michelsen A; Bendz B; Skårdal R; Smith HJ; Yndestad A; Ueland T; Aukrust P
    Int J Cardiol; 2013 Sep; 168(1):212-8. PubMed ID: 23046599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan hydrogels significantly limit left ventricular infarction and remodeling and preserve myocardial contractility.
    Henning RJ; Khan A; Jimenez E
    J Surg Res; 2016 Apr; 201(2):490-7. PubMed ID: 27020836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
    Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction.
    Chandrashekhar Y; Sen S; Anway R; Shuros A; Anand I
    J Am Coll Cardiol; 2004 Jan; 43(2):295-301. PubMed ID: 14736452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
    Dedkov EI; Bogatyryov Y; McCooey DS; Christensen LP; Weiss RM; Tomanek RJ
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure.
    Fu F; Zhao K; Li J; Xu J; Zhang Y; Liu C; Yang W; Gao C; Li J; Zhang H; Li Y; Cui Q; Wang H; Tao L; Wang J; Quon MJ; Gao F
    Sci Rep; 2015 Dec; 5():17927. PubMed ID: 26659007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
    Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic resonance imaging in small animal models of human heart failure.
    Nahrendorf M; Hiller KH; Hu K; Ertl G; Haase A; Bauer WR
    Med Image Anal; 2003 Sep; 7(3):369-75. PubMed ID: 12946475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
    Xu K; George I; Klotz S; Hay I; Xydas S; Zhang G; Cerami A; Wang J
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):506-12. PubMed ID: 20881614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical algorithms for pharmacologic management of the post myocardial infarction patient.
    Reiffel JA; ;
    Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I28-37. PubMed ID: 16450810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
    Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction.
    Allijn IE; Czarny BMS; Wang X; Chong SY; Weiler M; da Silva AE; Metselaar JM; Lam CSP; Pastorin G; de Kleijn DPV; Storm G; Wang JW; Schiffelers RM
    J Control Release; 2017 Feb; 247():127-133. PubMed ID: 28065862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.